Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing

International Psychogeriatrics

Volumn 22, Issue 3, 2010, Pages 437-444

  Zhang, Ying ^a   Chow, Veronica ^b   Vitry, Agnes I ^b   Ryan, Philip ^a   Roughead, Elizabeth E ^b   Caughey, Gillian E ^b   Ramsay, Emmae N ^a   Gilbert, Andrew L ^b   Esterman, Adrian ^b   Luszcz, Mary A ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Aging; Antidepressant; Depression; Longitudinal study

Indexed keywords

ANTIDEPRESSANT AGENT; MIANSERIN; MOCLOBEMIDE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; AGING; ANXIETY; ARTICLE; AUSTRALIA; COGNITION; COGNITIVE DEFECT; DEPRESSION; DEPRESSION INVENTORY; DRUG USE; ELDERLY CARE; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL DISEASE; QUESTIONNAIRE; RATING SCALE; SELF CONCEPT; SEX DIFFERENCE; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT INDICATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; AUSTRALIA; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952420349     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209991554     Document Type: Article

References (41)

1. Anstey, K. J. and Luszcz, M. A. (2002). Selective non-response to clinical assessment in the longitudinal study of ageing: Implications for estimating population levels of cognitive function and dementia. International Journal of Geriatric Psychiatry, 17, 704-709.
2. Anstey, K. J., van Sanden, C., Sargent-Cox, K. and Luszcz, M. A. (2007). Prevalence and risk factors for depression in a longitudinal, population based study including individuals in the community and residential care. American Journal of Geriatric Psychiatry, 165, 497-505.
3. Australian Government and Department of Health and Ageing (2008). Australian Statistics on Medicines 2006. Canberra: Australian Government and Department of Health and Ageing.
4. Ballinger, G. A. (2004). Using generalized estimating equations for longitudinal data analysis. Organizational Research Methods, 7, 127-150.
5. Blazer, D. G., Hybels, C. F., Fillenbaum, G. G. and Pieper, C. F. (2005). Predictors of antidepressant use among older adults: have they changed over time? American Journal of Psychiatry, 162, 705-710.
6. Charles, J., Britt, H., Fahridin, S. and Miller, G. (2007). Mental health in general practice. Australian Family Physician, 36, 200-201.
7. Clarke, D. M., Cook, K., Smith, G. C. and Piterman, L. (2008). What do general practitioners think depression is? A taxonomy of distress and depression for general practice. Medical Journal of Australia, 188, S110-113.
8. Esposito, D., Wahl, P., Daniel, G., Stoto, M. A., Erder, M. H. and Croghan, T. W. (2009). Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clinical Therapeutics, 31, 644-656.
9. Esposito, E., Wang, J. L., Adair, C. E., Williams, J. V., Dobson, K. and Schopflocher, D. (2007). Frequency and adequacy of depression treatment in a Canadian population sample. Canadian Journal of Psychiatry, 52, 780-789.
10. Folstein, M. F., Robins, L. N. and Helzer, J. E. (1983). The Mini-mental State Examination. Archives of General Psychiatry, 40, 812.
11. Folstein, M., Anthony, J. C. and Parhad, I. (1985). The meaning of cognitive impairment in the elderly. Journal of the American Geriatrics Society, 33, 228-235.
12. Healy, D. and Aldred, G. (2005). Anti-depressant drug use and the risk of suicide. International Review of Psychiatry, 17, 163-172.
13. Henderson, S., Andrews, G. and Hall, W. (2000). Australia's mental health: an overview of the general population survey. Australian and New Zealand Journal of Psychiatry, 34, 197-205.
14. Jureidini, J. and Tonkin, A. (2006). Overuse of antidepressant drugs for the treatment of depression. CNS Drugs, 20, 623-632.
15. Kendrick, T., Dowrick, C., McBride, A., Howe, A., Clarke, P. and Maisey, S. (2009). Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ, 338, b750.
16. Kerse, N., Flicker, L., Pfaff, J. J., Draper, B., Lautenschlager, N. T. and Sim, M. (2008). Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One, 3, e2423.
17. Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J. and Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med, 5, e45.
18. Krupinski, J. and Tiller, J. W. (2001). The identification and treatment of depression by general practitioners. Australian and New Zealand Journal of Psychiatry, 35, 827-832.
19. Kwon, A., Bungay, K. M., Pei, Y., Rogers, W. H., Wilson, I. B. and Zhou, Q. (2003). Antidepressant use: concordance between self-report and claims records. Medical Care, 41, 368-374.
20. Luszcz, M. A., Giles, L., Eckermann, S., Edwards, P., Browne-Yung, K. and Hayles, C. (2007). The Australian Longitudinal Study of Ageing: 15 Years of Ageing in South Australia. Adelaide: South Australian Department of Families and Communities.
21. Mamdani, M., Rapoport, M., Shulman, K. I., Herrmann, N. and Rochon, P. A. (2005). Mental health-related drug utilization among older adults: prevalence, trends, and costs. American Journal of Geriatric Psychiatry, 13, 892-900.
22. Mant, A., Rendle, V. A., Hall, W. D., Mitchell, P. B., Montgomery, W. S. and McManus, P. R. (2004). Making new choices about antidepressants in Australia: the long view 1975-2002. Medical Journal of Australia, 181, S21-24.
23. Mathers, C. D., Vos, E. T., Stevenson, C. E. and Begg, S. J. (2000). The Australian Burden of Disease Study: measuring the loss of health from diseases, injuries and risk factors. Medical Journal of Australia, 172, 592-596.
24. McManus, P., Mant, A., Mitchell, P. B., Montgomery, W. S., Marley, J. and Auland, M. E. (2000). Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Medical Journal of Australia, 173, 458-461.
25. McManus, P., Mant, A., Mitchell, P., Britt, H. and Dudley, J. (2003). Use of antidepressants by general practitioners and psychiatrists in Australia. Australian and New Zealand Journal of Psychiatry, 37, 184-189.
26. Montagnier, D., Barberger-Gateau, P., Jacqmin-Gadda, H., Dartigues, J.-F., Rainfray, M. and Peres, K. (2006). Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: results from the Personnes Agées Quid Study. Journal of the American Geriatrics Society, 54, 1839-1845.
27. Page, A. N., Swannell, S., Martin, G., Hollingworth, S., Hickie, I. B. and Hall, W. D. (2009). Sociodemographic correlates of antidepressant utilisation in Australia. Medical Journal of Australia, 190, 479-483.
28. Pandya, R., Metz, L. and Patten, S. B. (2005). Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics, 46, 131-134.
29. Parker, G. (2007). Is depression overdiagnosed? Yes. BMJ, 335, 328.
30. Pfaff, J. J., Draper, B. M., Pirkis, J. E., Stocks, N. P., Snowdon, J. A. and Sim, M. G. (2009). Medical morbidity and severity of depression in a large primary care sample of older Australians: the DEPS-GP project. Medical Journal of Australia, 190, S75-80.
31. Radloff, L. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
32. Rubin, D. B. (1987). Multiple Imputation for Nonresponse in Surveys. New York: J. Wiley & Sons.
33. Sawada, N., Uchida, H., Suzuki, T., Watanabe, K., Kikuchi, T. and Handa, T. (2009). Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry, 9:38 doi:10.1186/1471-244X-9- 38.
34. Schafer, J. L. and Graham, J. W. (2002). Missing data: our view of the state of the art Psychological Methods, 7, 147-177.
35. Sonnenberg, C. M., Deeg, D. J., Comijs, H. C., van Tilburg, W. and Beekman, A. T. (2008). Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years. Journal of Affective Disorders, 111, 299-305.
36. StataCorp (2001). Statistical Software: Release 9.0. College Station, TX: Stata Corporation.
37. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A. and Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 252-260.
38. van Weel, C., van Weel-Baumgarten, E. and van Rijswijk, E. (2009). Treatment of depression in primary care. BMJ, 338, b934.
39. Whiteford, H. A. (2008). Depression in primary care: expanding the evidence base for diagnosis and treatment. Medical Journal of Australia, 188, S101-102.
40. Zautra, A. J., B. M. Maxwell and John W. Reich (1989). Relationship among physical impairment, distress, and well-being in older adults. Journal of Behavioral Medicine, 12, 543-557.
41. Zeger, S. L., Liang, K. and Albert, P. S. (1988). Models for longitudinal data: a generalized estimating equation approach. Biometrics, 44, 1049-1060.